Santa Cruz Good Times

Wednesday
Jan 28th
Text size
  • Increase font size
  • Default font size
  • Decrease font size

Historic Shift in Drug Research

news marijuanaSanta Cruz nonprofit MAPS could complete the first study of therapeutic whole-plant marijuana in 40 years

While stacks of independent research have affirmed the medicinal potentials of the cannabis plant, none received the official approval of the U.S. government. But soon we could be looking at the first federally sanctioned research to take place on marijuana in 40 years, outside of limited research by government organizations.

On March 14, marking a historic shift in U.S. drug policy, the Public Health Service (PHS) approved the protocols for a study of cannabis’ effects on 12 treatment-resistant combat veterans with Post Traumatic Stress Disorder (PTSD). The study is sponsored by the Santa Cruz-based Multidisciplinary Association for Psychedelic Studies (MAPS) and its protocols were already approved by the U.S. Food and Drug Administration (FDA) three years ago. They were also approved by the University of Arizona Institutional Review Board (IRB), and the University of Arizona has agreed to play host with psychiatrist and MD Sue Sisley as principal investigator.

MAPS has tried for more than 14 years to complete a federally sanctioned clinical research study of marijuana. So far, the National Institute on Drug Abuse (NIDA), which has a DEA-protected monopoly on the only legal supply of marijuana that can be used for FDA-regulated research, has refused to sell them cannabis. However, it seems that could be about to change.

A few years ago, Rick Doblin, executive director of MAPS, teamed up with Sisley to develop protocols for the PTSD study. In the United States, 22 veterans kill themselves per day according to statistics from the Department of Veterans Affairs, and often those suicides are related to PTSD symptoms. In recent years, more and more veterans have been speaking out about cannabis’ ability to mitigate PTSD. They say it doesn’t make them feel numb the way most prescription PTSD treatments do.

“This is a dire need, understanding PTSD, not just for combat vets but for all our citizens who are plagued by this,” Sisley said in a February article. “Any physician who’s also a human being can’t rest when we know that there’s something out there, in this case a plant, that has the potential to reduce human suffering.”

But while many vets are calling for increased access to marijuana medicine, the study in question would be the first-ever controlled, clinical study to look at using marijuana to treat PTSD in human patients.

Brad Burge, communications director for MAPS, notes that prior animal studies, among them a study using lab rats published in the scientific journal Nature, have shown that cannabis helps calm an overactive fear system.

Despite FDA approval, there was still a gaping problem until this month: In order to purchase NIDA weed, the PHS had to complete a third review process, as required by a 1999 guideline.

After the original study protocol was rejected by PHS in September 2011, MAPS resubmitted a revised protocol on Oct. 24, 2013. Then the line went dead for four months. Unlike FDA protocols, which require a response within 30 days, there is no timeline requiring PHS to respond. Finally, in the second week of March, PHS responded.

PHS approval matters because marijuana has more restrictions than any other illicit substance in the country. The federal government still lists it as a Schedule I substance—meaning a substance with “no currently accepted medical use and a high potential for abuse” according to the DEA. And, as required by the 1999 guideline, marijuana is the only Schedule I substance that requires an extra approval by the PHS, on top of FDA approval, before it can be studied. This makes pot the most difficult substance in the United States to research under federal law.

“If it can be shown that marijuana helps reduce depression and suicidality, which are things we want to explore in the study, then we can save a lot of lives,” says Burge, noting that the study would look at 50 vets, but would apply to anyone suffering from PTSD.

Burge notes that while the government does fund research and provide cannabis for some studies of isolated cannabinoids—for example looking just at THC or studies on synthetic cannabinoids—“they’re doing everything they can to prevent any form of research into the benefits of smoked, whole plant marijuana as a potential prescription medicine.”

While the PHS approval overcomes an enormous hurdle, MAPS still needs the DEA to sign off before it can purchase research-grade marijuana from NIDA. Then, the first government-approved, non-government study of marijuana in four decades can begin.

Comments (1)Add Comment
It's about time
written by Jason Porter Collinsworth, March 31, 2014
This is huge news for the medical marijuana industry. I'm glad they are finally focusing on marijuana instead of MDMA (ecstasy) or LSD.

Write comment
smaller | bigger

busy
 

Share this on your social networks

Bookmark and Share

Share this

Bookmark and Share

 

Force of Nature

Santa Cruz’s Carlie Statsky brings her love of the natural world to the hyper-personal art of wedding photography

 

Mercury Retrograde in Aquarius

The magical time of Mercury’s retrograde cycle is here once again, until Feb. 11, and then some. The Mercury retro cycle actually lasts eight weeks when we consider its retrograde shadow, giving us six months a year for review. We know the rules of Mercury retro: Be careful with everything; cars, driving, money, resources, friends, friendships, groups, interactions, thinking, talking, communications. Avoid big purchases, important meetings and important repairs. Mercury retrograde times are for review, reassessment and rest. Our minds are overloaded from the last Mercury retro. Our minds need to assess what we’ve done since October—eliminating what is not needed, keeping what’s important, preparing for new information in the next three months (till mid-May). Mercury in Aquarius retrograde … we reinvent ourselves, seek the unusual, we don’t hide, we’re just careful. We live in two worlds; outer appearances and inner reckonings, with both sides of our brain activated. Yet, like the light of the Gemini twins, one light waxes (inner world), the other (outer realities) wanes. Like Virgo, we see what’s been overlooked—assessing, ordering and organizing information. It’s an entirely inner process. When speaking we may utter only half of the sentence. We’re in the underworld, closer to Spirit, eyes unseeing, senses alerted, re-doing things over and over till we sometimes collapse. Because we’re in other realms, we’re wobbly, make mistakes, and don’t really know what we want. It’s not a time for decisions. Not yet. It’s a time of review. And completing things. Mercury retro: integration, slowing down, resolution, rapprochement.

 

The New Tech Nexus

Community leaders in science and technology unite to form web-based networking program

 

Film, Times & Events: Week of January 23

Santa Cruz area movie theaters >
Sign up for Good Times weekly newsletter
Get the latest news, events

RSS Feed Burner

 Subscribe in a reader

Latest Comments

 

Bye Bye Benten!

Benten closing, plus Award-winning gin, a massive burrito and chocolate review

 

Trout Gulch Vineyards

Scanning the shelves of Deluxe Foods of Aptos, which carries an impressive selection of local and imported wines, I picked up a bottle of Trout Gulch Vineyards Chardonnay 2012, described as “a local favorite” by the busy market.

 

Cremer House

What’s old is cutting-edge again in Felton

 

How are you going to make a tangible difference in your community this year?

Spread more kindness and compassion.